Annual report [Section 13 and 15(d), not S-K Item 405]

REVENUE (Tables)

v3.26.1
REVENUE (Tables)
12 Months Ended
Dec. 31, 2025
Revenue from Contract with Customer [Abstract]  
SCHEDULE OF DISAGGREGATION OF REVENUE

 

    Treatment     Services     Total     Treatment     Services     Total  
Revenue by Contract Type                                    
(In thousands)   Twelve Months Ended     Twelve Months Ended  
    December 31, 2025     December 31, 2024  
    Treatment     Services     Total     Treatment     Services     Total  
Fixed price   $ 45,097     $ 4,491     $ 49,588     $ 34,953     $ 18,750     $ 53,703  
Time and materials             12,086       12,086               5,414       5,414  
Total   $ 45,097     $ 16,577     $ 61,674     $ 34,953     $ 24,164     $ 59,117  

 

    Treatment     Services     Total     Treatment     Services     Total  
Revenue by generator                                    
(In thousands)   Twelve Months Ended     Twelve Months Ended  
    December 31, 2025     December 31, 2024  
    Treatment     Services     Total     Treatment     Services     Total  
Domestic government   $ 29,093     $ 14,247     $ 43,340     $ 24,487     $ 22,389     $ 46,876  
Domestic commercial     10,272       1,622       11,894       8,566       1,223       9,789  
Foreign government     4,686       489       5,175       509       463       972  
Foreign commercial     1,046       219       1,265       1,391       89       1,480  
Total   $ 45,097     $ 16,577     $ 61,674     $ 34,953     $ 24,164     $ 59,117  
SCHEDULE OF CONTRACT BALANCES

 

                Year-to-date     Year-to-date  
(In thousands)   December 31, 2025     December 31, 2024     Change ($)     Change (%)  
Contract assets                                
Unbilled receivables - current   $ 8,781     $ 4,990     $ 3,791       76.0 %
                                 
Contract liabilities                                
Deferred revenue   $ 7,007     $ 6,711     $ 296       4.4 %

 

The increase in unbilled receivables from 2024 to 2025 was primarily due to timing difference between completion of revenue recognition and agreed upon invoicing terms at one of our Treatment facilities.

 

                Year-to-date     Year-to-date  
(In thousands)   December 31, 2024     December 31, 2023     Change ($)     Change (%)  
Contract assets                                
Unbilled receivables - current   $ 4,990     $ 8,432     $ (3,442 )     (40.8 )%
                                 
Contract liabilities                                
Deferred revenue   $ 6,711     $ 6,815     $ (104 )     (1.5 )%
SCHEDULE OF CHANGES IN ACCOUNTS RECEIVABLE, NET OF CREDIT LOSSES

The following table represents changes in accounts receivable, net of credit losses, for the periods noted:

 

                Year-to-date     Year-to-date  
(In thousands)   December 31, 2025     December 31, 2024     Change ($)     Change (%)  
                                 
Accounts Receivable (net)   $ 11,228     $ 11,579     $ (351 )     (3.0 )%

 

                Year-to-date     Year-to-date  
    December 31, 2024     December 31, 2023     Change ($)     Change (%)  
                                 
Accounts Receivable (net)   $ 11,579     $ 9,722     $ 1,857       19.1 %